Vital Signs

Going Direct to Cut Costs
Health+Benefits Going Direct to Cut Costs
Q&A with Tom Malczewski, Head of Direct Contracting Partnerships and Vice President of Sales, Brighton Health Plan Solutions
Gene Therapy: Rarely Needed but Massively Expensive
Health+Benefits Gene Therapy: Rarely Needed but Massively Expensive
Q&A with Ryan Siemers, Principal, Aegis Risk
Loneliness Lingers
Health+Benefits Loneliness Lingers
Q&A with Dr. Jeremy Nobel, Professor, Harvard Medical School, and President and Founder, Foundation for Art & Healing
Who Benefits from Drug Price Negotiations?
Health+Benefits Who Benefits from Drug Price Negotiations?
Q&A with Shawn Gremminger, President and CEO, National Alliance of Healthcare Purchaser Coalitions